| May 9, 2013 |
May 9, 2013
Vical Reports First Quarter 2013 Financial Results and Progress in Key Development Programs
|
| May 7, 2013 |
May 7, 2013
Vical to Present at May Investor Conferences
|
| May 6, 2013 |
May 6, 2013
Vaxfectin(R) Enhances Preclinical Immune Responses to Baxter's Cell Culture-Derived Influenza Vaccines
|
| May 2, 2013 |
May 2, 2013
Vical Announces News Release and Conference Call Schedule for First Quarter 2013 Financial Results
|
| April 22, 2013 |
April 22, 2013
Vical CEO to Participate in Cancer Immunotherapy Panel at BIO International Convention
|
| February 27, 2013 |
February 27, 2013
Vical to Present at March Investor Conferences
|
| February 6, 2013 |
February 6, 2013
Vical Reports 2012 Financial Results and Progress in Key Development Programs
|
| February 5, 2013 |
February 5, 2013
Vical to Present at February Investor Conferences
|
| February 4, 2013 |
February 4, 2013
Vical Announces Publication of Herpes Simplex Vaccine Guinea Pig Study Data
|
| January 30, 2013 |
January 30, 2013
Vical Announces News Release and Conference Call Schedule for 2012 Financial Results
|
| January 3, 2013 |
January 3, 2013
Vical to Present at 31st Annual J.P. Morgan Healthcare Conference
|
| January 2, 2013 |
January 2, 2013
Vical Named to NASDAQ Global Select Market
|